Weedley

Company Overview

Snapshot

Founded in January 2019 by Dr. Erez Hanael, Itay Ben-Mordechai, and Sahar Meiron, Weedley operates with 1–10 employees. The company ceased operations in September 2019, having focused on developing and commercializing CBD products for pets.

Business overview

Weedley develops, commercializes, and markets CBD products for pets, including CBD oil drops, balms, and treats derived from European-grown organic whole hemp. These products aim to alleviate issues like anxiety and arthritis in cats, dogs, and horses by promoting homeostasis and acting as anti-inflammatories. The company serves pet owners globally through its online platform and operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Cannabis and Herbals for the Recreational & Lifestyle consumer market.

Strategic signal

In May 2019, Weedley announced a partnership with Pet Pace to research the efficacy of CBD in treating osteoarthritis symptoms in dogs and cats. This collaboration highlighted the company's commitment to scientific validation for its pet CBD products and signaled a strategic move towards integrating health monitoring technology with alternative veterinary treatments.

Company Intelligence Q&A

What is Weedley's primary focus?

Weedley develops, commercializes, and markets CBD products for pets, including oil drops, balms, and treats, derived from organic whole hemp.

When was Weedley founded and by whom?

Weedley was founded in January 2019 by Dr. Erez Hanael, Itay Ben-Mordechai, and Sahar Meiron.

What was a significant partnership for Weedley?

In May 2019, Gour Medical, Weedley's parent company, announced a partnership with Pet Pace to research how CBD can help treat osteoarthritis symptoms in dogs and cats.

What types of products does Weedley offer?

Weedley offers CBD oil drops, balms, and treats for pets, all derived from European-grown organic whole hemp.

What is the operational status of Weedley?

Weedley ceased to operate in September 2019.